IPO proceeds will scale up AI drug discovery
生成式AI药物发现公司英矽智能创始人兼首席执行官Alex Zhavoronkov讨论了公司在香港首次公开募股募资2.93亿美元后的计划。
English original
Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong Kong.
在香港IPO后接受CNBC采访时
A
亚历克斯·扎沃龙科夫Insilico Medicine · 创始人
报道摘要
Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong Kong. He ...
CNBC